ABCC7 p.Asp835*

[switch to full view]
Comments [show]
Publications
PMID: 10748197 [PubMed] Cahill P et al: "Identification of the cystic fibrosis transmembrane conductance regulator domains that are important for interactions with ROMK2."
No. Sentence Comment
53 These experiments were performed on oocytes expressing ROMK2/CFTR-K593X and ROMK2/CFTR-D835X and showed that the current was Ba2ϩ -sensitive Kϩ current and not stimulated Cl- current.
X
ABCC7 p.Asp835* 10748197:53:87
status: NEW
Login to comment

58 CFTR Constructs and Method of Mutagenesis-Cells were injected with ROMK2 alone, ROMK2/CFTR-WT, ROMK2/SUR, ROMK2/CFTR-D835X (a CFTR construct with an intact nucleotide binding fold and a functional R domain), ROMK2/CFTR-K593X (a CFTR construct with an intact nucleotide binding fold but no R domain), or ROMK2/ RT2N2CFTR (a CFTR construct containing the R domain, the second nucleotide binding fold domain, the second transmembrane domain, and the first 159 bases of CFTR-WT so as to include the Kozak methionine for translation initiation) (Fig. 1).
X
ABCC7 p.Asp835* 10748197:58:117
status: NEW
Login to comment

61 The oligonucleotides used for mutagenesis were CFTR-K593X, 5Ј-CTGTTAACTGATGGCT- AGCAAACTAGG-3Ј and CFTR-D835X, 5ЈCACGAAAAGTGTCACTGG- CCCCTCAGGCAAACTTCGATATATTACTGTCCACAAGAGCTTAAT- TTTGTGC-3Ј.
X
ABCC7 p.Asp835* 10748197:61:116
status: NEW
Login to comment

65 CFTR-D835X and CFTR-K593X are expressed at membrane level, in varying expression systems (9, 19).
X
ABCC7 p.Asp835* 10748197:65:5
status: NEW
Login to comment

77 Schematic representation of CFTR-WT (A), RT2N2CFTR (B), a CFTR mutant containing the R domain, transmembrane domain 2, NBF2, and the initial 159 bases of CFTR-WT so as to include the Kozak methionone for translation initiation, CFTR-K593X (C), a CFTR mutant truncated at residue 593, with an intact NBF1 and CFTR-D835X (D), a CFTR mutant truncated after the R domain.
X
ABCC7 p.Asp835* 10748197:77:313
status: NEW
Login to comment

85 However, when ROMK2 and CFTR-D835X (a CFTR construct with an intact nucleotide binding fold and a functional R domain) were co-expressed and stimulated with the cAMP- enhancing mixture, the resultant Kϩ current demonstrated an attenuated sulfonylurea response (26 Ϯ 5% inhibition, n ϭ 16) (Fig. 4).
X
ABCC7 p.Asp835* 10748197:85:29
status: NEW
Login to comment

86 In the absence of FSK/IBMX there was a 48 Ϯ 10% inhibition of Kϩ current when ROMK2 and CFTR-D835X were co-expressed (n ϭ 9) (Table I, Figs. 2-4).
X
ABCC7 p.Asp835* 10748197:86:105
status: NEW
Login to comment

91 This suggests that the ROMK2/SUR proteins remain functionally interactive under conditions that increase cAMP-dependent phosphorylation unlike the ROMK/CFTRWT and ROMK2/CFTR-D835X proteins.
X
ABCC7 p.Asp835* 10748197:91:174
status: NEW
Login to comment

96 Conditions that promote phosphorylation did not alter the glibenclamide insensitive FIG. 2. Effect of glibenclamide on whole cell Ba2ϩ -sensitive Kϩ currents for ROMK2 when co-expressed with CFTR-D835X, CFTR-K593X, or RT2N2CFTR under basal conditions (in the absence of FSK/IBMX) (A, B, and E) in Xenopus oocytes, using two-microelectrode voltage clamp techniques.
X
ABCC7 p.Asp835* 10748197:96:208
status: NEW
Login to comment

103 A representative family of whole cell currents from oocytes injected with either ROMK2/CFTR-D835X or ROMK2/ CFTR-K593X, and traces under basal conditions (in the absence of FSK/IBMX) and after stimulation with FSK/IBMX (100 ␮M/1 mM) are compared.
X
ABCC7 p.Asp835* 10748197:103:92
status: NEW
Login to comment

105 It demonstrates that in ROMK2/ CFTR-K593X-injected oocytes, glibenclamide inhibition of whole cell Kϩ current remains prominent, despite application of FSK/IBMX, but that in ROMK2/CFTR-D835X-injected oocytes the FSK/IBMX mixture attenuates this inhibitory response.
X
ABCC7 p.Asp835* 10748197:105:191
status: NEW
Login to comment

120 d p value Ͻ0.05 when comparing % glibenclamide inhibition of whole cell Kϩ current under basal conditions and after stimulation with FSK/IBMX for R2/D835X where there is attenuation of inhibitory response with FSK/IBMX.
X
ABCC7 p.Asp835* 10748197:120:161
status: NEW
Login to comment

122 FIG. 4. Effect of glibenclamide on Ba2؉ -sensitive currents obtained from Xenopus oocytes using two-microelectrode voltage clamp techniques. Summary of data obtained for ROMK2, ROMK2/ CFTR-WT, ROMK2/CFTR-D835X, ROMK2/CFTR-K593X, and ROMK2/SUR, as indicated on the x axis. Represented on the y axis is the percentage of total barium-sensitive Kϩ current inhibited by glibenclamide.
X
ABCC7 p.Asp835* 10748197:122:210
status: NEW
Login to comment

125 FIG. 5. Effect of glibenclamide on Ba2؉ -sensitive currents obtained from Xenopus oocytes using two-microelectrode voltage clamp techniques. Summary of data obtained for ROMK2, ROMK2/ RT2N2CFTR, ROMK2/CFTR-WT, and ROMK2/CFTR-D835X as indicated on the x axis. Represented on the y axis is the percentage of total barium-sensitive Kϩ current inhibited by glibenclamide.
X
ABCC7 p.Asp835* 10748197:125:231
status: NEW
Login to comment

128 In contrast, the first half of the CFTR molecule (CFTR-D835X), when co-expressed with ROMK2, behaves in a similar pattern to ROMK2/CFTR-WT and assumes sensitivity to sulfonylureas.
X
ABCC7 p.Asp835* 10748197:128:55
status: NEW
Login to comment